Top Stocks Today - Invest Million

Trillium Therapeutics Inc (NASDAQ: TRIL) Rallies After Positive Data On TTI-621 Dosage

Trillium Therapeutics Inc (NASDAQ: TRIL) was a big gainer in yesterday’s trading session, and closed the day with gains of 93.96%. This came after the company announced progress on its TTI-621 and TTI-622 clinical programs. The CEO, Jan Skvarka announced that, the

NASDAQ: VSTM

Verastem Inc (NASDAQ: VSTM) Gains After Partnership With Chugai Pharma For The development Of CH5126766

Verastem Inc (NASDAQ: VSTM) was one of the top gainers in yesterday’s trading session. The followed an announcement that, the company had entered into a global licensing agreement with Chugai Pharmaceuticals CO. Ltd. Under the agreement, Verastem Inc. will get global development and

Financial

Apellis Pharmaceuticals (NASDAQ: APLS) Trades Up On Positive Phase 3 PEGASUS Results and Public Stock Offer News

Apellis Pharmaceuticals Inc (NASDAQ: APLS) made significant gains in yesterday’s trading session, as it closed the day with gains of 28.29%. This followed several major announcements both in science and finance. On the scientific front, the company announced that it had positive

Investments

CLPS Incorporation (NASDAQ: CLPS) Rallies After Integrating Two Singapore-Based Subsidiaries

CLPS Incorporation (NASDAQ: CLPS) was one of the top gainers just ahead of Christmas. The stock rallied to close the day with gains of 47.13%. This came after it announced that, it had completed the integration of Infogain Pte Ltd and RidKik Pte

Breaking News

Microbot Medical (NASDAQ: MBOT) Soars After Announcing a Breakthrough in LIBERTY, a Technology For Remote Operations

Microbot Medical (NASDAQ: MBOT) was one of the top gainers just ahead of Christmas, and closed the day with gains of 61.03%. This followed the company’s announcement that, it was unveiling the world’s first disposable robotic system for cardiovascular, neurovascular and

Breaking News

Breaking News: Amneal Pharmaceuticals Inc (NYSE: AMRX) Spikes on FDA Approval of EluRyng

Amneal Pharmaceuticals Inc (NYSE: AMRX) rallied in Thursday’s trading session after months of sluggish performance. This followed news that the company had received FDA approval for its vaginal ring called EluRyng, which is the first generic version of NuvaRing. According to the